RayBiotech

RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities.

RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit.

RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011 and will accept applications for restricted pilot grants of $5,000 to $20,000 worth of RayBiotech products and/or services beginning in early 2011.

RayBiotech, Inc., today announced the release of several antibody array products that can detect up to 34 proteins related to the recently discovered Th17 lineage of immune cells in a single assay.

RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis.

RayBiotech, Inc., and Gentel Biosciences jointly announced today their partnership to develop and market RayBiotech's vast collection of antibody array products for use with Gentel's sensitive and affordable APiX™ chromogenic detection platform.

RayBiotech announced the recipients of its Biomarker Discovery Grants. By sponsoring these awards, RayBiotech intends to demonstrate that any researcher with a modest research budget can discover disease-related biomarkers using its antibody arrays.

RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010.

A study in the December issue of Nature Cell Biology identified a potential drug target for breast cancer. RayBiotech Antibody Arrays were vital to this discovery, including one detecting phosphorylation of EGFR family receptors at multiple sites.

RayBiotech, the Protein Array Pioneer Company, has just introduced the Quantibody® Human Cytokine Array 4000 (or Human Q4000), which can quantitatively detect expression of 200 different proteins in a single experiment.